These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18046966)

  • 41. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Candidaemia and antifungal susceptibility testing in a teaching hospital.
    Tzar MN; Shamim AS
    Med J Malaysia; 2009 Mar; 64(1):61-4. PubMed ID: 19852325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
    Liu P; Zhu S; Li P; Xie W; Jin Y; Sun Q; Wu Q; Sun P; Zhang Y; Yang X; Jiang Y; Zhang D
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3261-5. PubMed ID: 18467095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antifungal effect of amine fluoride-stannous fluoride combination on oral Candida species.
    Meurman JH; Kari K; Waltimo T; Kotiranta A; Inkeri J; Samaranayake LP
    Oral Dis; 2006 Jan; 12(1):45-50. PubMed ID: 16390468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
    Khan ZU; Randhawa HS; Chehadeh W; Chowdhary A; Kowshik T; Chandy R
    Int J Antimicrob Agents; 2009 Jun; 33(6):559-63. PubMed ID: 19195846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait.
    Asadzadeh M; Al-Sweih NA; Ahmad S; Khan ZU
    Mycoses; 2008 Jul; 51(4):318-23. PubMed ID: 18855844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of subgingival colonization of Candida albicans and other yeasts with severity of chronic periodontitis.
    Canabarro A; Valle C; Farias MR; Santos FB; Lazera M; Wanke B
    J Periodontal Res; 2013 Aug; 48(4):428-32. PubMed ID: 23137301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2).
    Rodriguez-Tudela JL; Donnelly JP; Pfaller MA; Chryssantou E; Warn P; Denning DW; Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M
    J Clin Microbiol; 2007 Jan; 45(1):109-11. PubMed ID: 17093015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
    da Silva Barros ME; de Assis Santos D; Soares Hamdan J
    Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic diversity and exoenzyme activities of Candida albicans and Candida dubliniensis isolated from the oral cavity of Brazilian periodontal patients.
    Barros LM; Boriollo MF; Alves AC; Klein MI; Gonçalves RB; Höfling JF
    Arch Oral Biol; 2008 Dec; 53(12):1172-8. PubMed ID: 18672229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z; Sobel JD
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antifungal resistance: an emerging problem in Mexico].
    Manzano-Gayosso P; Méndez-Tovar LJ; Hernández-Hernández F; López-Martínez R
    Gac Med Mex; 2008; 144(1):23-6. PubMed ID: 18619054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diversity and antifungal susceptibility of yeasts from tropical freshwater environments in Southeastern Brazil.
    Medeiros AO; Kohler LM; Hamdan JS; Missagia BS; Barbosa FA; Rosa CA
    Water Res; 2008 Aug; 42(14):3921-9. PubMed ID: 18678387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
    Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.